DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

121.77 -3.10 (-2.48%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JAZZ $121.77 -2.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $124.67
Previous Close $124.87
Daily Range $121.19 - $126.24
52-Week Range $116.15 - $194.73
Market Cap $7.5B
P/E Ratio 23.88
Dividend (Yield) $0.00 (0.0%)
Volume 507,223
Average Daily Volume 626,852
Current FY EPS $5.58




Drug Makers

Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website:

News & Commentary Rss Feed

Ignore Regeneron Pharmaceuticals, Inc: Here Are 3 Better Buys Right Now

Thinking about investing in Regeneron? Here are three names you might want to consider instead.

Jazz's Phase III Data on Defibrotide Published in ASH Journal

Veltassa Boasts Favorable Drug Interaction Data While ZS-9 Regulatory Concerns Loom

Insider Trading Alert - RSPP, JAZZ And OMN Traded By Insiders

Trade-Ideas: Jazz Pharmaceuticals (JAZZ) Is Today's "Barbarian At The Gate" Stock

Over 1,000 Stocks On The NYSE Just Hit 52-Week Lows

Insider Trading Alert - RT, VLGEA And JAZZ Traded By Insiders Daily Round Up 1/14/16: REGN, PEIX, SRE, ARDX

3 Stocks To Watch In Thursday's After-Hours Session

Why Flamel Technologics S.A. Tumbled 15% Today

A new competitor is expected to cause sales in Flamel's top-selling drug to drop significantly this year.

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $121.77 (-2.48%)
Current stock: JAZZ
JNJ $100.54 (-3.23%)
Current stock: JNJ
NVS $74.33 (-0.97%)
Current stock: NVS
RHHBY $31.69 (-1.18%)
Current stock: RHHBY